BIOCHIPS - A GLOBAL STRATEGIC BUSINESS REPORT   

Research Abstract

This report analyzes the worldwide markets for Biochips in US$ Million by the following product segments - DNA Chips, Protein Chips, and Lab Chips. Annual estimates and forecasts are provided for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia Pacific, Middle East, and Latin America. The report profiles 77 companies including many key and niche players such as Affymetrix, Agilent Technologies, Biomerieux, Bio-Rad Laboratories, Inc., Caliper Life Sciences, Cepheid Inc., GE Healthcare Ltd., Life Technologies Corporation, Ocimum Biosolutions Ltd., Takara Bio, Inc., Clontech Laboratories, Inc., and Zyomyx. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Code : MCP-1026
Price : $4500
Companies : 77
Pages : 630
Date : February 2011
Market Data Tables : 47

Complimentary Report Insights:


Request a Complimentary Copy of the Study’s Key Findings, Drivers, Trends, Program Sources, and Methodology.
Salutation:
First Name:
Last Name:
Email ID: (Domain Specific Email Required)
Company:
NOTE: Generic Email IDs such as AOL, Hotmail, Yahoo, Gmail, MSN etc. cannot be used

 TABLE OF CONTENTS


 
   Study Reliability and Reporting Limitations.......1  
   Disclaimers.......2  
   Data Interpretation & Reporting Level.......3
Quantitative Techniques & Analytics.......3
Product Definitions and Scope of Study.......3
A. DNA Chips.......3
  
   B. Protein Chips.......4
C. Lab Chips.......4
  
   A Primer.......5
Recession Dries Up Funds for Biotech Firms.......5
1$100
   Promising Biochips Promote Biological Research.......61$100
   Current and Future Analysis.......7
Key Forces Driving the Industry.......7
DNA Chips Lead the Application Front.......7
1$100
   Protein Biochips – Set for Robust Expansion.......8
Lab-on-a-Chips: Fusion of Nanotechnology & Genetic Engineering.......8
1$100
   Industry Challenges.......9
Standardization: A Key Challenge.......9
Price Dearness Pauses Biochips Growth.......9
1$100
   Current Approaches to Biochips.......10
The Business of Biochips.......10
1$100
   Technological Differentiation in Demand.......11
Focus on Highly Intelligent Diagnostic Systems.......11
Scalability & Pricing – Focus Areas.......11
1$100
   Biochips: Expanding Role in Diagnostic Medicine.......12
Advancements in Biochip Technology.......12
1$100
   Biochip Technology Boosts Personalised Medicine.......13
Biochip Technology Spreads beyond Pharma Industry.......13
1$100
   Proteomics “Chip” into Biochip Technology.......14
Towards Increasing Minaturization.......14
Technological Trends.......14
Sensitivity.......14
Microfabrication.......14
1$100
   Density.......15
Integrated Chips.......15
Patent Trends.......15
Table 1: Number of Lab-on-a-Chip Patents (includes corresponding Graph/Chart).......15
1$300
   Table 2: % of Lab-on-a-Chip Patent Documents by Country/ Authority of Origin (January 2008 – April 2009) (includes corresponding Graph/Chart).......16

Table 3: Number of Lab-on-a-Chip Documents by Patent Assignees (January 2008 – April 2009) (includes corresponding Graph/Chart).......16
1$300
   Patent Applications.......171$100
   Industry Structure.......18
Major Participants.......18
Affymetrix: A Major Market Player.......18
1$100
   Other Market Players.......19
Growing Partnerships between Pharma and Biotech Companies.......19
1$100
   Tech Giants Join the Biochip Fray.......201$100
   Biochips – Complex Blend of Biochemistry and Electronics.......21
Historical Perspective.......21
2$200
   Lab-on-a-chip: An Enabled Technology.......23
Utility .......23
Evolution and Segmentation.......23
Differing Perspectives.......23
1$100
   Classification of Biochips.......241$100
   Need for Biochips.......25
Manufacturing Systems Used in Biochip Manufacture.......25
1$100
   Working of a Biochip.......26
DNA Transcription & Translation Through A Biochip.......26
A Functional Model.......26
1$100
   Cocktail of Disparate Technically Specialized Applications.......27
Biochips: By-product of Multi-disciplinary Sciences.......27
Nanotechnology.......27
BioMEMS.......27
1$100
   Microfluidics.......28
Micro Total Analysis System.......28
2$200
   Chip Architecture.......30
Essence of a Biochip.......30
Concept of a Microarray.......30
Microarray Modules.......30
1$100
   High Degree of Automation Spurs Biochips Use.......31
Microfabrication Technology in Biochips made from Polymer and Plastics.......31
1$100
   Micro-optics in Biochips.......32
Liquid Handling Through Micro-Dispensers.......32
Capillary Electrophoresis and Electrochemical Detectors.......32
Other Technologies.......32
Management of Bio-information.......32
1$100
   Scanning.......33
Microarray Database Management.......33
Classification of DNA Chips.......33
General Description of Spotted Cdna Microarrays.......33
1$100
   Spotted DNA Arrays.......34
Spotted Cdna Versus Spotted Oligonucleotide Arrays.......34
Limitations of Conventional Cdna Microarrays.......34
1$100
   Protein Biochips.......35
General Applications of Protein Biochips.......35
1$100
   Challenges in the Design of a Protein Biochip.......36
Limitations of Protein Chip Technology.......36
1$100
   Concluding Remarks for Protein Biochips.......371$100
   Applications Of Biochips.......381$100
   Biochip Uses.......39
Pharmaceutical Investigation.......39
Medical Diagnostics.......39
1$100
   Advantages of Biosensor Chip Technology.......40
Forensics.......40
Transplantation Screening.......40
Identity Testing.......40
1$100
   Water and Environmental Testing.......41
Food Industry.......41
1$100
   Randox Launches Evidence Evolution Analyzer.......42
South Korea Develops Instant Microfluidic Biochip.......42
Fluidigm Introduces Reusable FR48.48 Dynamic Array™ IFC.......42
Cellix Introduces Vena4Y™ and Vena4Y2™ Biochips.......42
1$100
   Agilent Technologies Unveils Workflow HPLC-Chip.......43
Febit Holding Introduces First Human Cancer Biochip.......43
1$100
   Blue4Green Rolls Out Lab-on-a-chip Solution.......44
Randox Laboratories Unveils Biochip Arrays.......44
Randox Laboratories Introduces Evidence Investigator.......44
1$100
   Randox Unveils Innovative DoA Biochips for Rapid Drug Screening.......45
Randox Launches Revolutionary Biochip Analyser for Multiple Cardiac Testing.......45
1$100
   Febit Unveils Biochip for DNA/RNA Detection and Enrichment on Mouse Genome.......46
Veredus Laboratories Launches Portable Test Kit for H1N1 Flu.......46
Randox Develops Multi Marker Cardiac Biochip Array for MI Diagnosis.......46
1$100
   VigeneTech and CapitalBio Launch Completely Integrated Microarray Solution
  Platform.......47
1$100
   Randox Introduces New Biochip Array for CAMs Testing.......48
Cellix Announces Global Launch of VenaEC Biochip.......48
Decision Biomarkers Rolls Out AVANTRA™ Biomarker Workstation System.......48
1$100
   Osaka Develops Biocompatible Monomers for Biochips.......49
Iris BioTechnologies Launches New Nano-Biochip.......49
Affymetrix Introduces Complete Cytogenetic Solution.......49
1$100
   Agilent Unveils 244K CGH Micro-Array.......50
Randox Unveils World’s First Protein Biochip.......50
Randox Introduces Thyroid Array Biochip.......50
1$100
   Sigma Launches ChIP Kit.......51
Randox Develops Biochip for Synthetic Steroids.......51
US and Czech Scientists to Develop Biochips for Detecting Cancer.......51
Manchester University Researchers Develop New Protein Chips Manufacturing
  Procedure.......51
1$100
   febit Introduces New Geniom Biochip.......521$100
   Agilent Introduces Additions to the HPLC-Chip Line for Proteomics.......53
Progenika Develops BLOODchip.......53
Roche Introduces Gene Expression Services and Arrays.......53
1$100
   Stratos Biosystems Develops New EC-Affinity Biochips.......54
Affymetrix Unveils Affymetrix GeneChip Command Console Software.......54
1$100
   Affymetrix Introduces GeneChip Mouse and Rat Gene 1.0 ST Arrays.......55
Affymetrix Unveils Genome-Wide Human SNP Array 6.0.......55
Caliper Life Sciences Launches High Throughput RNA Assay.......55
1$100
   Applied Biosystems Unveils DNA Tools.......56
febit Launches Geniom RT Analyzer.......56
1$100
   Austrian Research Center Develops New Biochip Surface.......57
Researchers Develop Biochips to Eliminate Animal Testing.......57
Progenika Biopharma Launches IBD DNA.......57
Bioident Develops New Lab-on-a-Chip Nanotiter Plate Prototype.......57
1$100
   Ilochip and University of Denmark Develop a Biochip for Faster Bird Flu
  Detection.......58
CombiMatrix Develops a Biochip for Leukemia Analysis.......58
Affymetrix Launches New Tiling Arrays for Mapping Whole-Genome Transcript.......58
1$100
   Roche Plans to Launch AmpliChip in Japan.......59
Caliper Life Sciences Unveils Desktop Profiler.......59
Massachusetts Institute of Technology Develops Portable Lab on a Chip.......59
Optical Device to Develop Lab-on-a-Chip.......59
1$100
   Agilent Launches Five New HPLC Chips.......60
Protagen AG Launches New Protein Biochips.......60
Fluidigm Releases the 8.96 TOPAZ Screening Chip.......60
Affymetrix Releases Chip-on-Chip Array.......60
DNA Chip Research Launches High Sensitivity DNA Chip.......60
DNA Chip Research and HitachiSoft Unveils AceGene.......60
1$100
   Philips and bioMerieux to Produce Biochips for Cardiovascular Assays.......61
Roche Diagnostics and CapitalBio to Sign MOU.......61
SVTC Partners with TSMC to Commercialize New Technologies.......61
1$100
   HORIBA Jobin Yvon Takes Over GenOptics.......62
GWC Technologies to Receive $100,000 Federal Grant.......62
febit to Receive Funds for Biomarker Project.......62
1$100
   Researchers Assess TB-Biochip MDR Test System.......63
IBM to Use DNA Chip for Developing Personalized Medicine.......63
1$100
   Invitrogen and Applied Biosystems Merge to Form Life Technologies Corporation.......64
China Medical Technologies Signs Agreement with Molecular Diagnostics
  Technologies.......64
DNA Chip Acquires HuBit’s Gene Analysis Business.......64
1$100
   Affymetrix Acquires USB.......65
Roche NimbleGen Forms Alliance with BioDiscovery to Provide CGH Solutions.......65
Illumina Announces Partnership with Genpathway for ChIP Sequencing Services.......65
1$100
   Jiangsu and IMDi Diagnosis to Establish Joint Venture.......66
Plexera Biosciences Enters into an Option Deal with Auguron.......66
1$100
   Affymetrix and Avesthagen Enter into an Agreement.......67
Roche NimbleGen and Affymetrix Announce Expansion of License Agreement.......67
Proteomika and Auguron Biosciences Ink Option Agreement.......67
1$100
   Gentel Biosciences and Eppendorf Enter into Global License Agreement.......68
GATC Biotech Establishes New Subsidiary.......68
1$100
   Procognia Spins off Sense Proteomic.......69
Johns Hopkins University Purchases MassARRAY System.......69
Yale University Purchases MassARRAY System.......69
Korea’s NIH Extends KARE Project with Affymetrix Technology.......69
1$100
   febit Obtains US Patent for Hybselect, a Microfluidic Extraction Method.......70
Atotech Enters into Research Collaboration with University of Albany.......70
CapitalBio and Beijing National Engineering Research Center Develop New Biochip Testing
  System.......70
1$100
   Roche Takes Over NimbleGen.......71
GenTel BioSciences Acquires Protein Chip Platform Assets of GSK.......71
1$100
   Advanced Liquid Logic Acquires Nanolytics.......72
Applied Microarrays Acquires Select GE Healthcare’s Assets.......72
1$100
   Canon, Toshiba and Other Companies to Join Hands for Biochips.......73
BioChip Innovations Signs Research Collaboration Agreement with IME.......73
Protagen Enters into a Partnership to Develop Antibodies.......73
1$100
   Spanish Society of Rheumatology Enters into Collaboration with Progenika.......74
Affymetrix and Partners Healthcare Extend Collaboration.......74
Agencourt, NuGEN and Affymetrix Clinical Services Collaborate.......74
1$100
   Affymetrix Inks Licensing Agreement with Empire Genomics.......75
Caliper Enters into a Licensing Agreement with Monogram Biosciences.......75
1$100
   Affymetrix and IPSOGEN Sign Agreement.......76
bioMérieux and NuGEN Enter into Supply and Cross-License Agreement.......76
1$100
   VWR and CapitalBio Enter into a Distribution Agreement.......77
C3B Bags Contract from Department of Defense to Develop an Implantable Biochip.......77
UCL Subsidiary and Roche Diagnostics Ink Licensing Deal.......77
1$100
   Affymetrix Establishes the European Cytogenetic Research Initiative.......78
Fluidigm Establishes New Development Center.......78
Daiichi Pure Chemicals Applies for Approval to Market DNA Micro-array.......78
1$100
   GE Healthcare Snaps Up Biacore.......79
Bio-Rad Acquires Ciphergen’s Life Science Research Business.......79
Sysmex to Form Partnership with Affymetrix.......79
Daiichi, Toshiba Hokuto and Toshiba Join Hands.......79
1$100
   Affymetrix Collaborates with Zhejiang California Nanosystem Institute.......80
Merck Sharp & Dohme and Shanghai Biochip Enter into Co- operation Agreement.......80
1$100
   Toshiba Signs Licensing Agreement with Antara BioSciences.......81
MUSC Signs LOI with Lumera.......81
AVIVA Inks Agreement with Japan’s Cosmo Bio.......81
Lumera Signs Collaborative Agreement with Harvard Medical School.......81
1$100
   Whatman Receives CE Mark for CombiChip.......82
IDIBAPS Led Project Receives Approval from European Union.......82
1$100
   Toray to Establish DNA Chip Business.......83
Protagen Forays into the US Market.......83
Biacore Expands Operations into Chinese Market.......83
Nisshinbo to Replace Glass with Resin in DNA Production.......83
1$100
   Affymetrix Inc (US).......84
Agilent Technologies, Inc. (US).......84
1$100
   Biomerieux SA (France).......85
Bio-Rad Laboratories, Inc. (US).......85
Caliper Life Sciences, Inc. (US).......85
1$100
   Cepheid Inc. (US).......86
GE Healthcare Ltd. (UK).......86
Life Technologies Corporation (US).......86
1$100
   Ocimum Biosolutions Ltd. (India).......87
Takara Bio, Inc. (Japan).......87
1$100
   Clontech Laboratories, Inc. (US).......88
Zyomyx Inc (US).......88
1$100
   Table 4: World Recent Past, Current & Future Analysis for Biochips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......891$300
   Table 5: World Historic Review for Biochips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......901$300
   Table 6: World 11-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......911$300
   Table 7: World Recent Past, Current & Future Analysis for DNA Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......921$300
   Table 8: World Historic Review for DNA Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......931$300
   Table 9: World 11-Year Perspective for DNA Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......941$300
   Table 10: World Recent Past, Current & Future Analysis for Protein Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......951$300
   Table 11: World Historic Review for Protein Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......961$300
   Table 12: World 11-Year Perspective for Protein Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......971$300
   Table 13: World Recent Past, Current & Future Analysis for Lab Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......981$300
   Table 14: World Historic Review for Lab Chips by Geographic Region – US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......991$300
   Table 15: World 11-Year Perspective for Lab Chips by Geographic Region – Percentage Breakdown of Dollar Sales for US, Canada, Japan, Europe, and Rest of World Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1001$300
   A. Market Analysis.......101
Outlook.......101
An Insight into Biochip Products & Services Market.......101
Rapid Growth for Protein, Lab Biochips.......101
1$100
   Robust Demand for Biochip Reagents and Consumables.......102
Growth Prospects for Biochip Instruments & Software.......102
1$100
   Potential for Biochip Service Revenues.......103
Biochip Product & Service Demand Among Biotech Companies.......103
Biochip Products and Services Demand in Life Science Research Applications.......103
1$100
   Laboratory Chips Market.......104
Table 16: US Laboratory Chip Market by Application (2007 & 2015P): Percentage Share Breakdown of Revenues for Life Science Research, Forensic Medicine, In Vitro Diagnostic Testing, Drugs-of- Abuse Testing, Disease Management, and Others (includes corresponding Graph/Chart).......104
1$300
   Competitive Landscape.......105
Table 17: Leading Players in the US Biochip Products and Services Market (2007): Percentage Share Breakdown of Revenues for Illumina, Affymetrix, Applied Biosystems, GE/Amersham, Invitrogen, Bio-Rad, Caliper Life Science, Cepheid, Agilent Techs, Beckman Coulter, and Others (includes corresponding Graph/Chart).......105
1$300
   B. Market Analytics.......106
Table 18: US Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......106

Table 19: US Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......106
1$300
   Table 20: US 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1071$300
   Market Analysis.......108
Table 21: Canadian Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......108
1$300
   Table 22: Canadian Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......109

Table 23: Canadian 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......109
1$300
   A. Market Analysis.......110
Outlook.......110
ICAN ™ Technology for Large-Scale Production of DNA Fragments.......110
1$100
   B. Market Analytics.......111
Table 24: Japanese Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......111
1$300
   Table 25: Japanese Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1121$300
   Table 26: Japanese 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1131$300
   A. Market Analysis.......114
Outlook.......114
Lab-on-chip Market in Europe.......114
1$100
   European Advancements Shape Diagnostic Procedures.......1151$100
   B. Market Analytics.......116
Table 27: European Recent Past, Current & Future Analysis for Biochips by Geographic Region – France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......116
1$300
   Table 28: European Historic Review for Biochips by Geographic Region – France, Germany, UK, and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1171$300
   Table 29: European 11-Year Perspective for Biochips by Geographic Region – Percentage Breakdown of Dollar Sales for France, Germany, UK, and Rest of Europe Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1181$300
   Table 30: European Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......1191$300
   Table 31: European Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1201$300
   Table 32: European 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1211$300
   Market Analysis.......122
Table 33: French Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......122
1$300
   Table 34: French Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1231$300
   Table 35: French 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1241$300
   A. Market Analysis.......125
Outlook.......125
Berlin, Brandenburg and Biochips.......125
1$100
   B. Market Analytics.......126
Table 36: German Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......126
1$300
   Table 37: German Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1271$300
   Table 38: German 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1281$300
   Market Analysis.......129
Table 39: UK Recent Past, Current & Future Analysis for Biochips by Product Segments– DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......129
1$300
   Table 40: UK Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1301$300
   Table 41: UK 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1311$300
   Market Analysis.......132
Table 42: Rest of Europe Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......132
1$300
   Table 43: Rest of Europe Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1331$300
   Table 44: Rest of Europe11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1341$300
   A. Market Analysis.......135
Outlook.......135
China.......135
Basic Environment and Commercial Development.......135
1$100
   Biochip Research Institutes.......136
Taiwan.......136
Taiwan Pursues Promise of Biochip Sector.......136
1$100
   International Advantage Sought.......1371$100
   B. Market Analytics.......138
Table 45: Rest of World Recent Past, Current & Future Analysis for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2007 through 2015 (includes corresponding Graph/Chart).......138
1$300
   Table 46: Rest of World Historic Review for Biochips by Product Segment – DNA Chips, Protein Chips and Lab Chips Markets Independently Analyzed with Annual Sales Figures in US$ Million for Years 2000 through 2006 (includes corresponding Graph/Chart).......1391$300
   Table 47: Rest of World 11-Year Perspective for Biochips by Product Segment – Percentage Breakdown of Dollar Sales for DNA Chips, Protein Chips and Lab Chips Markets for Years 2005, 2010 & 2015 (includes corresponding Graph/Chart).......1401$300
  
Total Companies Profiled: 77 (including Divisions/Subsidiaries - 87)

Region/Country Players

The United States 40 Japan 14 Europe 24 France 4 Germany 8 The United Kingdom 4 Spain 1 Rest of Europe 7 Asia-Pacific (Excluding Japan) 9
Click here to request a full table of contents and more details on this project.